Abdomenable Transactions

Episode Summary

Executive Summary: The episode explores how economist Al Roth helped design kidney exchange markets that match incompatible donor-recipient pairs, enabling about 6,000 transplants in the U.S. It also broadens into “repugnant transactions,” arguing that many valuable markets can function without prices through careful design. The discussion extends this logic to refugee resettlement and dating markets.

Main Topics: Kidney exchange as market design (Priority: 5/5): Roth explains how economists helped create matching systems for incompatible donor-recipient pairs, using algorithms and databases to maximize transplants without money. Why kidneys are not priced (Priority: 5/5): The conversation covers the legal ban on organ sales, ethical concerns about exploitation, and the distinction between legality and social acceptance. Algorithms and logistics in transplantation (Priority: 5/5): Roth describes top trading cycles, pair exchanges, larger cycles, and non-directed donor chains as mechanisms that increase successful transplants. Constraints of the U.S. transplant system (Priority: 4/5): The episode highlights shortages of deceased donor kidneys, the dominance of dialysis, reimbursement frictions for donor expenses, and the role of Medicare. Repugnant transactions and market design (Priority: 4/5): The discussion frames kidney sales, plasma donation, and prostitution as examples of markets that may be legal in some places but still socially stigmatized. Other matching markets: refugees and dating (Priority: 4/5): Roth applies matching-market thinking to refugee resettlement and dating apps, emphasizing thickness, congestion, safety, and effective allocation.

Key Arguments: Kidney shortages are the main bottleneck, not just matching: about 100,000 people wait for deceased-donor transplants while only about 13,000 are done annually. Because kidney sales are illegal in most countries, economists must design non-price mechanisms that still allocate scarce organs efficiently. Living donor pairs often cannot donate directly due to incompatibility, so exchange mechanisms can create mutually beneficial swaps. Small pairwise exchanges are limited by surgical logistics, but larger cycles and chains can substantially raise the number of successful transplants. Non-directed donors can start chains that produce long sequences of transplants, making kidney exchange much more effective. Legalizing payment does not automatically remove stigma; Iran’s kidney market is legal, but Roth says it still appears socially repugnant and possibly inefficient. Market-design tools can improve other non-price allocation problems, including refugee resettlement and dating platforms, by increasing market thickness and reducing congestion.

Data Points: Lives saved via kidney exchange: about 6,000 - Roth’s mechanism has led to roughly this many transplants in the United States. People waiting for deceased donor transplants: 100,000 - Estimated number waiting in the U.S. at the time discussed. Annual deceased donor transplants: about 13,000 per year - U.S. transplant volume for deceased-donor kidneys. Living donor transplants aided by kidney exchange: 10% to 15% - Share of U.S. living donor transplants attributed to kidney exchange. Medicare budget share: 7% - Kidney failure costs account for this share of Medicare spending. Chain length average: 5 transplants - Average U.S. kidney exchange chain for a period referenced in the interview. School/market coordination example: 4 kidney exchanges among 14 transplant centers - Early New England context before organized market design. Operating rooms needed for simultaneous two-pair exchange: 4 operating rooms - Two nephrectomies and two transplants must happen at once for a two-pair swap. Waiting period for private insurance before Medicare eligibility: 33 months - Private insurers cover kidney failure for this period before Medicare takes over.

Pivotal Quotes: "there have been about six thousand transplants arising through kidney exchange in the United States" — Al Roth: He answers the opening question about the impact of his mechanism. "one of the big obstacles is reaching people who have kidney failure early in the course of their disease and letting them know that transplantation is a possibility" — Al Roth: He identifies a major barrier to expanding transplants. "there's no shortage of kidneys, there's a surplus because you have two" — Al Roth: He summarizes his view that the legal and organizational problem, not absolute scarcity of potential living kidneys, is central.

Implications: The episode shows that well-designed matching mechanisms can save lives even when prices are banned. It suggests similar tools could improve refugee placement, organ exchange, and dating platforms by solving coordination failures rather than relying on markets with money.